board has considered and approved the following business transactions in the meeting: The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Wellness Ltd's board, meeting on August 12, 2025, approved its unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2025). Total income from operations more than doubled to ₹2,328.37 lakh from ₹1,110.55 lakh in the same quarter last year, a growth of about 110%. Profit after tax surged roughly 4.5 times to ₹115.67 lakh (standalone) from ₹25.50 lakh a year ago, with EPS rising to ₹0.24 from ₹0.079. The statutory auditor, Bakliwal & Co., issued an unmodified limited review report on both sets of results. The board also declined a request from Mrs. Pallavi Mittal to reclassify her shareholding from promoter to public category. The company highlighted new product launches (Brain Fuel capsules), a foray into diagnostics and home sample collection, and the launch of a digital teleconsultation platform called Aayush Health.
Very strong Q1 print with revenue and PAT more than doubling year-on-year signals accelerating demand and improved operating leverage, which is positive for short-term sentiment. However, base-effect tailwinds and the board's decision to keep the promoter reclassification request on hold may limit governance-related rerating; investors should watch whether the new healthcare and digital initiatives sustain growth beyond the low base.